According to the study, medications known as selective serotonin reuptake inhibitors, or SSRIs, are frequently used to treat seasonal affective disorder. There are several branded and generic medications available on the seasonal affective disorder therapeutics market size however, buproban and citalopram continue to sell at a relatively higher rate. FMI credits this dominance to the widely accessible …
Category Archives: Healthcare Trends
Dental Lasers Market Set to Shine Bright, Projected to Illuminate at US$ 737.4 Million by 2033-FMI Projection
It is anticipated that the dental lasers market will be worth US$ 737.4 million by 2033 and US$ 492.2 million by 2023. Dental laser sales are anticipated to increase during the course of the anticipated year at a notable CAGR of 4.1%. The recent advancements in laser technology have also contributed to the steady growth …
Cytomegalovirus Treatment Market Surges to a Remarkable US$ 326 Million by 2028-FMI Projection
In 2022, the global cytomegalovirus treatment market is expected to be worth US$ 228.8 million. Demand for cytomegalovirus treatment is expected to reach US$ 326 Million by the end of 2028, growing at a CAGR of 6.1% (2022 to 2028). The industry that treats cytomegaloviruses (CMVs) is leading the charge in combating a powerful viral …
Chemotherapy-Induced Treatment Market Envisions a Steady 3.2% CAGR Journey Through 2028-FMI Projection
With a 3.3% cumulative annual growth rate (CAGR), the chemotherapy-induced myelosuppression treatments market is predicted to rise from its current size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028. A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in …
Antibiotic Susceptibility Testing Market Sets Sights on US$ 4.05 Billion Revenue by 2028-FMI Projection
In 2021, the antibiotic susceptibility testing market generated US$ 2.82 billion in revenue. By 2028, the global market is projected to have grown at a compound annual growth rate of 5.2% and be valued US$ 4.05 billion. •Infectious diseases, prevailing at a high pace •Increasing rate and tenure of hospitalization •Growing significance of early diagnostics •Soaring …
Laboratory Balances and Scales Market Surges Beyond US$ 2.0 Billion by 2033-FMI Projection
Between 2023 and 2033, the laboratory balances and scales market is projected to grow at a 4.3% average CAGR. The market is anticipated to grow from its predicted value of US$ 1.31 billion in 2023 to a market share of US$ 2.0 billion by 2033. •The market expansion is fueled by the increased use of …
Prothrombin Complex Concentrates Market Sets Sail on a US$ 1.2 Billion Odyssey by 2033-FMI Projection
From a predicted US$ 772.0 million in 2023, the prothrombin complex concentrates market sales is expected to reach a valuation of US$ 1.2 billion by 2033. Demand for prothrombin complex concentrate is expected to rise at a steady 4.1% CAGR, with China, India, the US, and the UK emerging as key producers. The global Prothrombin …
Global Surgical Drapes Industry is forecasted to experience a 4.2% CAGR from 2023 to 2033, driven by the increasing need for effective solutions in managing chronic diseases, as per FMI
According to a recently released Future Market Insights study, the global surgical drapes industry size is expected to generate sales of US$ 1.4 billion in 2023 and expand at a CAGR of 4.2% from 2023 to 2033. The market is anticipated to reach US$ 2.1 billion by the end of 2033. From 2023 to 2033, …
Global Complicated Urinary Tract Infections Treatment Industry is on track for growth, projected to experience a 5.76% CAGR by 2033 | FMI
The global complicated urinary tract infections treatment industry demand is expected to surpass an impressive valuation of US$ 9.2 billion in 2023 and is projected to reach US$ 16.1 billion by 2033, trailing a CAGR of 5.76%. An advanced platform called biosensors are used for the diagnosis of complicated urinary tract infection which will drive …
Global Oncology-based In-Vivo CRO Industry is expected to attain US$ 2.9 Billion by 2033, growing consistently at a 10.9% CAGR, according to FMI
The global oncology-based in-vivo CRO industry size is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033. The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along …